Marina Biotech Completes Dosing of Second Cohort in the Phase 1b START-FAP Clinical Trial of CEQ508

Marina Biotech Regains Intellectual Property Rights to its tkRNAi™ Technology for Agriculture and Veterinary Uses

Marina Biotech Announces Worldwide Exclusive Licensing Agreement with Monsanto

Marina Biotech Receives Three Notices of Allowances from the USPTO and an Intent to Grant Notice from the European Patent Office

Marina Biotech and Girindus Group Announce Strategic Alliance

Marina Biotech Ceases Most Day-to-Day Operations

Marina Biotech Announces Worldwide Non‐Exclusive Licensing Agreement for Nucleic Acid Chemistry

Marina Biotech Provides Update on Company Operations

Marina Biotech, Inc. Announces Full Year 2011 Financial Results

Marina Biotech Announces Worldwide Non-Exclusive Licensing Agreement with Nucleic Acid Chemistry to Tekmira Pharmaceuticals